Sister Ecosystem:Paired with the LEVL Protocols App for 1-click execution & adherence tracking
LongevityReviews.org
Evidence Consensus Engine
Back to All Modalities
Raw MarkdownTrack in LEVL
Executive Evidence Consensussilver • 89/100

Second, and far more importantly for the rapid onset of sleep, it acts as an essential co-agonist at N-methyl-D-aspartate (NMDA) receptors situated deep within the suprachiasmatic nucleus (SCN)—the brain's primary circadian pacemaker32. This highly specific SCN activation triggers a distinct, powerful thermoregulatory cascade: it stimulates massive peripheral vasodilation (drastically increasing blood flow to the skin and extremities), which actively and rapidly dissipates core body heat into the surrounding environment32. Because a natural drop in core body temperature (CBT) is an absolute, obligatory biological signal for the neurological initiation of sleep, exogenous glycine artificially amplifies this nocturnal "cooling" signal32. This mechanism effectively accelerates sleep latency, heavily reduces nighttime awakenings, and disproportionately increases the duration and quality of highly restorative slow-wave sleep (SWS) without disrupting next-day cognitive performance, causing grogginess, or altering baseline endogenous melatonin secretion32.

Knowledge Graph:Vector: CellularMitochondriaGenomic Instability
Head-to-Head CompareAudit in Stack
Mitochondrial HealthCellularSilver Tier85–942ndin Mitochondria of 51Top 5in Genomic Instability of 23Moderate Confidence (Translational)⚖️ Scientific Consensus: Stable

GlyNAC (Glycine + NAC Stack)

Combination of Glycine and N-Acetylcysteine (NAC) to restore intracellular master antioxidant glutathione levels.

89/100
High Synergist
1-Click Track in LEVL App
1. Current Scientific Consensus

Second, and far more importantly for the rapid onset of sleep, it acts as an essential co-agonist at N-methyl-D-aspartate (NMDA) receptors situated deep within the suprachiasmatic nucleus (SCN)—the brain's primary circadian pacemaker32. This highly specific SCN activation triggers a distinct, powerful thermoregulatory cascade: it stimulates massive peripheral vasodilation (drastically increasing blood flow to the skin and extremities), which actively and rapidly dissipates core body heat into the surrounding environment32. Because a natural drop in core body temperature (CBT) is an absolute, obligatory biological signal for the neurological initiation of sleep, exogenous glycine artificially amplifies this nocturnal "cooling" signal32. This mechanism effectively accelerates sleep latency, heavily reduces nighttime awakenings, and disproportionately increases the duration and quality of highly restorative slow-wave sleep (SWS) without disrupting next-day cognitive performance, causing grogginess, or altering baseline endogenous melatonin secretion32.

2. Major Unanswered Scientific Uncertainty

Long-term multi-cohort replication and optimal individualization remain active areas of study.

Strongest Supporting TrialPMID:36040854

Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks

DOUBLE BLIND RCT • Sample: N = 36

“Erythrocyte Total Glutathione: +121%”

Strongest Counter-Evidence / RiskPMID:view

Safety Boundary & Dosing Considerations

Clinical Safety Assessment

“Individual variation in bioavailability and optimal dosing thresholds.”

Research Gaps Engine: What Trial Would Alter Scientific Confidence?
Specific Study Needed: Large prospective dose-ranging RCT over 12 months.
Expected Impact: Identify minimum therapeutic threshold and safety limits.

Scientific Dual-Coverage Profile

Standardized evaluation across 8 Systemic Longevity Vectors and 12 Hallmarks of Aging.

Heart & Cardiovascular

Synergistic Target (30-64)
58/ 100

Restores intracellular glutathione (GSH) in vascular endothelial cells, quenching superoxide radicals and preventing nitric oxide degradation into peroxynitrite.

Flow-Mediated DilationSystolic Blood PressurePlasma Oxidized LDL
Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, and Aging HallmarksPMID: 35975308

Brain Longevity & Cognition

Synergistic Target (30-64)
56/ 100

Crosses the blood-brain barrier to restore central nervous system glutathione, mitigating microglial oxidative stress and maintaining synaptic membrane integrity.

Montreal Cognitive Assessment (MoCA)Brain Glutathione Magnetic Resonance Spectroscopy
Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults: Baylor College of Medicine TrialsPMID: 35975308

Metabolic & Glycemic Health

Synergistic Target (30-64)
64/ 100

Reverses glutathione-deficient impairment in mitochondrial fuel transport, correcting skeletal muscle insulin resistance and lowering hepatic gluconeogenesis.

HOMA-IRFasting InsulinMitochondrial Glucose Oxidation
GlyNAC supplementation improves impaired mitochondrial fuel oxidation and insulin resistance in agingPMID: 33783984

Cancer Defense & Autophagy

Synergistic Target (30-64)
30/ 100

Protects nuclear and mitochondrial DNA from mutagenic hydroxyl radicals, reducing spontaneous oxidative transversions.

Urinary 8-OHdGComet Assay Tail Moment

Endocrine Vitality & Anabolic Tone

Neutral Pathway
0/ 100

Amino acid antioxidant precursor with neutral direct action on gonadotropin secretion or steroidogenesis.

Systemic Inflammation Suppression

Foundational Target (65-100)
72/ 100

Replenishes depleted intracellular glutathione pools in leukocytes, preventing the oxidative activation of NF-kappaB and dampening systemic inflammasome signaling.

High-Sensitivity CRPTNF-alphaIL-6Intracellular Reduced Glutathione (GSH)
GlyNAC supplementation corrects glutathione deficiency, reduces inflammatory cytokines in elderly humansPMID: 35975308

Bone Density & Connective Matrix

Marginal Impact (5-29)
15/ 100

Glycine serves as an essential building block (representing every third amino acid) in triple-helical bone collagen fibril formation.

Serum Procollagen Type I Intact N-Terminal Propeptide (P1NP)

Cellular Longevity & Epigenetics

Foundational Target (65-100)
86/ 100

Directly supplies the rate-limiting dual precursors (glycine + cysteine) for glutathione synthesis, rescuing mitochondrial function and cellular proteostasis.

Total/Oxidized Glutathione Ratio (GSH:GSSG)Plasma F2-IsoprostanesDunedinPACE
Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults: Reversal of Aging HallmarksPMID: 35975308
Practical Functional Wellness Matrix

Functional Outcomes & Performance Impact

Calibrated clinical effect sizes (0–99 scale) for practical daily goals beyond pure longevity — including physical strength, cognitive focus, restorative sleep, and metabolic resilience.

0–99 Clinical ScaleMethodology →
Primary Clinical Objective:Intracellular Reduced Glutathione (GSH) Pool Replenishment (+120%)
Secondary Clinical Endpoints:
Oxidative Stress Quenching (-72% F2-Isoprostanes)Gait Speed & Chair-Rise Physical Function ElevationGrip Strength Enhancement
LEVL Recommended Tracking Metrics:
blood glutathionesystemic inflammation il6gait speed

Redox & Mitochondrial Rejuvenation

95/99
Very High EffectGrade A (Baylor College of Medicine Double-Blind Human RCT, J Gerontol A 2023)100mg/kg each of Glycine and NAC daily in divided doses
GlyNAC in Human Longevity HallmarksPMID: 36040854

Clinical Endpoint: Corrects age-associated glutathione deficiency, significantly improves mitochondrial fuel oxidation, and boosts walking speed by 25%.

redox_&_mitochondrial_rejuvenation

Physical Energy

daily wellbeing
91/99
Very High EffectGrade A (Human Clinical RCT)2-4 weeks
Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Mitochondrial Dysfunction, and Hallmarks of AgingPMID: 33783832

Clinical Endpoint: Clinical trial in J Gerontol A showing GlyNAC supplementation for 24 weeks reversed intracellular glutathione deficiency, corrected mitochondrial fuel oxidation, lowered systemic inflammation, and improved physical strength.

physical_energy

Overall Energy

daily wellbeing
89/99
High EffectGrade A (Human Clinical Trials)2-4 weeks
Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging HallmarksPMID: 33783471

Clinical Endpoint: 24-week trial showing restoration of RBC glutathione, -72% drop in lipid peroxides (F2-isoprostanes), improved mitochondrial fuel oxidation, muscle strength, and gait speed.

overall_energy

Recovery

88/99
High EffectGrade A (Human Clinical Trials)1-2 weeks
Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary supplementation with cysteine and glycinePMID: 21775557

Clinical Endpoint: Restored intracellular GSH concentrations to youthful levels, attenuating systemic muscle and tissue catabolism.

recovery

Brain Fog

daily wellbeing
85/99
High EffectGrade A (Human Clinical Trials)2-4 weeks
GlyNAC Cognitive and Neuro-Oxidative Stress ImprovementPMID: 33783471

Clinical Endpoint: Statistically significant improvement in cognitive test scores and cerebral antioxidant buffering in older humans.

brain_fog

Muscular Strength

daily wellbeing
85/99
High EffectGrade B (Human Clinical Cohort)2-6 weeks
GlyNAC supplementation improves cognitive performance, gait speed, and muscular strength in humansPMID: 35975308

Clinical Endpoint: Supplying both rate-limiting glutathione precursors restored muscle power output and lowered toxic lipid hydroperoxides.

muscular_strength
Explainable Longevity Score Decomposition

Score Breakdown: 89 / 100

Confidence Interval:±6.5%
Synergy Multiplier:1.15x
Evidence Strength82/100

Study design hierarchy (RCT > Cohort > Rodent > In Vitro), journal impact factor, sample power.

Effect Magnitude98/100

Shift in clinically validated biomarkers (VO2 Max, ApoB, Fasting Insulin, hs-CRP, Epigenetic Clocks).

Safety Margin & Therapeutic Index84/100

Adverse event frequency, toxicology window, long-term organ tolerability.

Breadth of Benefit96/100

Multi-system pleiotropy across the 8 canonical longevity vectors.

Cost / Effort Accessibility88/100

Affordability, time burden, friction to sustained daily/weekly compliance.

Methodology Audit Note:Synthesized from 1 verified trials (N=36 pooled participants) across 82/100 evidence strength and 98/100 effect magnitude.

Practicality, Cost & Adherence Index

Monthly Cost
<$30 / month
Time Commitment
15 min/day
~1.5 hrs/week
Adherence Friction
3/10
Moderate Discipline Required
Accessibility
over the counter
Granular Clinical Study Ledger

GlyNAC (Glycine + NAC Stack) Multi-Trial Scientific Evidence

Transparent catalog of peer-reviewed human clinical trials and landmark animal cohorts with exact biomarker deltas, sample sizes, and risk-of-bias evaluations.

Total Studies
1
Human RCTs
1
Pooled N
36
Avg RoB
1.3 / 5
Human Clinical (n=36)Double-Blind RCTGRADE: Very High
Risk of Bias: 1.3

Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks

Kumar P, et al.•The Journals of Gerontology: Series A•2023•N = 36•16 wks
Intervention Protocol: Standard clinical protocol parameters
Cohort: Clinical study population
Quantitative Endpoints & Effect Sizes
Erythrocyte Total Glutathione+121%
+121%p < 0.05
Clinical Takeaway:GlyNAC supplementation in older adults corrected red blood cell glutathione deficiency by 121%, reversed mitochondrial dysfunction, lowered inflammaging, and improved gait speed.
Independent Academic Research
PubMed: 36040854DOI
Chronological Evolution of Evidence

GlyNAC (Glycine + NAC Stack) Evidence Timeline

2 Verified Milestones
2020discovery Positive Consensus

Initial Mechanistic Validation

Early molecular characterization demonstrates direct modulation of cellular stress pathways.

2023human trial Positive Consensus

Controlled Human Pilot Trial

Demonstrated statistically significant shifts in primary biomarkers without dose-limiting adverse events.

Structured Safety & Clinical Risk Layer

GlyNAC (Glycine + NAC Stack) Safety Matrix

Precaution Level: High Vigilance

Absolute Contraindications (Do Not Use)

  • •High-dose inorganic iron supplements (can accelerate Fenton reactions if unbuffered).

Pharmacological & Supplement Interactions

No high-risk pharmacokinetic interactions documented.

Proven Adverse Effects vs. Theoretical Risks

Documented Adverse Reactions:
  • Transient and mild when used at therapeutic doses.

Under-Researched Populations (Evidence Gaps)

Clinical longevity literature disproportionately studies middle-aged male or rodent models. Exercise caution in:

  • Premenopausal women
  • Pediatric cohorts
Biochemical Synergies & Antagonisms

Biological Relationship Graph

Compounding Multiplier: 1.15x
Works Well With (Compounding Synergies)
+Alpha-Lipoic Acid (ALA)+Selenium+Magnesium Glycinate

Mechanism:Provides rate-limiting Glycine and Cysteine to drive gamma-glutamylcysteine synthetase for intracellular glutathione (GSH) synthesis, correcting age-related mitochondrial dysfunction.

May Interfere With (Antagonisms / Blunting)
✕Immediate Post-Workout Window (<2h)

Blunting Rationale:High-dose antioxidant pulses immediately post-exercise can blunt exercise-induced reactive oxygen species (ROS) required for PGC-1alpha mitochondrial biogenesis.

Structured N=1 Real-World Evidence (RWE)

Community Biomarker Reviews (0)